How is quantitative analysis evolving?

Pharmacogenetic testing in Canada – what plan sponsors need to know

Migraine
Read interview with Émilie Bortolussi-Courval

What kind of impact has biosimilar switching policies had on group insurance plans, and what can we expect in the future?

Marie-France Amyot, Senior vice-president of group and business insurance, Desjardins Insurance, and Vice-president of business development, Desjardins Insurance, share their insights.

Benefits Canada’s September issue is our annual women’s issue, where organizations have the opportunity to feature their top female leaders.